Castle Biosciences (NASDAQ:CSTL) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Castle Biosciences missed estimated earnings by 1.32%, reporting an EPS of $-0.77 versus an estimate of $-0.76.
Revenue was up $12.08 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.26 which was followed by a 5.79% increase in the share price the next day.
Here’s a look at Castle Biosciences’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.71 | -0.47 | -0.40 | -0.37 |
| EPS Actual | -0.97 | -0.25 | -0.47 | -0.34 |
| Revenue Estimate | 25.21M | 23.74M | 22.97M | 18.93M |
| Revenue Actual | 26.85M | 25.04M | 23.48M | 22.76M |
To track all earnings releases for Castle Biosciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
